CASTLE ROCK, CO--(Marketwire - April 25, 2008) - AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, announced its board of directors have authorized a stock repurchase plan to purchase shares of the company's common stock up to a maximum of $5.0 million.
